Kazazian Asset Management, LLC XBI Holdings History
Kazazian Asset Management, LLC's SPDR Biotech ETF Holding Summary
As of 2025-03-31, Kazazian Asset Management, LLC held - shares of SPDR Biotech ETF(XBI), totaling N/A. This investment constitutes 0% of their stock portfolio, and Kazazian Asset Management, LLC now holds 0% of the outstanding SPDR Biotech ETF(XBI) stock.
The initial trade took place in 2024Q4. And since then Kazazian Asset Management, LLC has made 1 purchases of XBI, at an average price of $96.87, for a total of 31,893.00 shares. In addition, there have been 1 sales at an average price of $89.38 for 31,893.00 shares. Based on historical transaction data and XBI's current price of $87.49, Kazazian Asset Management, LLC's estimated gain on his XBI holdings is $-238,878.57, reflecting a -7.73% gain to date.
Kazazian Asset Management, LLC XBI ($87.49) Holding Chart
Kazazian Asset Management, LLC XBI ($87.49) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
